Condition
Malignant Bone Tumor
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Terminated1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07113301Active Not RecruitingPrimary
Incisional Biopsy Versus Core-needle Biopsy in Bone Tumors Analysis
NCT04740749Not ApplicableTerminated
Longevity, Functional Status and Quality of Life of the Compress® Compliant Pre-Stress System
NCT06302465Not ApplicableRecruitingPrimary
Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
NCT06120426Recruiting
En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.
Showing all 4 trials